These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 22708303

  • 1. [HIV preexposure prophylaxis].
    Olczak A, Grabczewska E.
    Przegl Epidemiol; 2012; 66(1):79-82. PubMed ID: 22708303
    [Abstract] [Full Text] [Related]

  • 2. Oral preexposure anti-HIV prophylaxis for high-risk U.S. populations: current considerations in light of new findings.
    Myers GM, Mayer KH.
    AIDS Patient Care STDS; 2011 Feb; 25(2):63-71. PubMed ID: 21284497
    [Abstract] [Full Text] [Related]

  • 3. Pre-exposure chemoprophylaxis of HIV infection: quo vadis?
    Clercq ED.
    Biochem Pharmacol; 2012 Mar 01; 83(5):567-73. PubMed ID: 22067069
    [Abstract] [Full Text] [Related]

  • 4. Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2012 Aug 10; 61(31):586-9. PubMed ID: 22874836
    [Abstract] [Full Text] [Related]

  • 5. Early end for FEM-PrEP HIV prevention trial.
    AIDS Patient Care STDS; 2011 Jun 10; 25(6):383. PubMed ID: 21612547
    [No Abstract] [Full Text] [Related]

  • 6. Considerations regarding antiretroviral chemoprophylaxis in MSM.
    Poynten IM, Zablotska I, Grulich AE.
    Curr Opin HIV AIDS; 2012 Nov 10; 7(6):549-56. PubMed ID: 22918448
    [Abstract] [Full Text] [Related]

  • 7. Generic Truvada approved.
    AIDS Patient Care STDS; 2009 May 10; 23(5):395. PubMed ID: 19422066
    [No Abstract] [Full Text] [Related]

  • 8. Tenofovir: quo vadis anno 2012 (where is it going in the year 2012)?
    De Clercq E.
    Med Res Rev; 2012 Jul 10; 32(4):765-85. PubMed ID: 22581627
    [Abstract] [Full Text] [Related]

  • 9. The risk of HIV drug resistance following implementation of pre-exposure prophylaxis.
    van de Vijver DA, Boucher CA.
    Curr Opin Infect Dis; 2010 Dec 10; 23(6):621-7. PubMed ID: 20847692
    [Abstract] [Full Text] [Related]

  • 10. Oral preexposure prophylaxis for HIV--another arrow in the quiver?
    Michael NL.
    N Engl J Med; 2010 Dec 30; 363(27):2663-5. PubMed ID: 21091280
    [No Abstract] [Full Text] [Related]

  • 11. [Simply convincing. New fixed combination for HIV therapy].
    MMW Fortschr Med; 2005 Apr 25; 147 Spec No 1():20-3. PubMed ID: 16385865
    [No Abstract] [Full Text] [Related]

  • 12. Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidence.
    Celum C, Baeten JM.
    Curr Opin Infect Dis; 2012 Feb 25; 25(1):51-7. PubMed ID: 22156901
    [Abstract] [Full Text] [Related]

  • 13. Systemic preexposure prophylaxis for human immunodeficiency virus infection.
    Romanelli F, Murphy B.
    Pharmacotherapy; 2010 Oct 25; 30(10):1021-30. PubMed ID: 20874040
    [Abstract] [Full Text] [Related]

  • 14. Antiretroviral medications as prevention: will the new paradigm reverse the HIV epidemic?
    Henry K.
    Minn Med; 2012 Aug 25; 95(8):48-50. PubMed ID: 22953476
    [Abstract] [Full Text] [Related]

  • 15. Effects of nucleoside reverse transcriptase inhibitor backbone on the efficacy of first-line boosted highly active antiretroviral therapy based on protease inhibitors: meta-regression analysis of 12 clinical trials in 5168 patients.
    Hill A, Sawyer W.
    HIV Med; 2009 Oct 25; 10(9):527-35. PubMed ID: 19785663
    [Abstract] [Full Text] [Related]

  • 16. [Tenofovir in Study 903. Also effective and tolerable in first-line therapy].
    MMW Fortschr Med; 2002 Aug 22; 144(33-34):61. PubMed ID: 12380158
    [No Abstract] [Full Text] [Related]

  • 17. Preexposure prophylaxis for the prevention of HIV transmission to women.
    Aaron E, Cohan D.
    AIDS; 2013 Jan 02; 27(1):F1-5. PubMed ID: 22914582
    [Abstract] [Full Text] [Related]

  • 18. Emtricitabine + tenofovir to prevent HIV transmission. More evaluation needed.
    Prescrire Int; 2013 Jul 02; 22(140):178-81. PubMed ID: 23951592
    [Abstract] [Full Text] [Related]

  • 19. [First nucleotide analog against HIV. Lowers viral load also in drug resistance].
    MMW Fortschr Med; 2002 Aug 22; 144(33-34):60-1. PubMed ID: 12380157
    [No Abstract] [Full Text] [Related]

  • 20. Determinants of high-risk sexual behavior during post-exposure prophylaxis to prevent HIV infection.
    Golub SA, Rosenthal L, Cohen DE, Mayer KH.
    AIDS Behav; 2008 Nov 22; 12(6):852-9. PubMed ID: 17682938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.